Mirglow 7.5mg Tablet
Marketer
Surge Pharmaceuticals Pvt Ltd
Salt Composition
Mirtazapine (7.5mg)
Overview Mirglow 7.5mg Tablet
Lumira 7.5mg tablets are indicated for depressive disorders. This medication elevates brain levels of serotonin and norepinephrine, neurotransmitters that promote calmness and nerve relaxation, thereby alleviating depressive symptoms. Lumira 7.5mg tablets can be administered with or without food. Consistent daily dosing at the same time ensures stable blood levels. If a dose is missed, take it immediately upon recollection. Do not omit doses; complete the prescribed course even with symptom improvement. Abrupt cessation should be avoided to prevent symptom exacerbation. Commonly reported side effects include xerostomia, increased hunger, and cephalalgia. Drowsiness and vertigo may occur; avoid driving or activities requiring concentration until the drug's effects are known. Weight gain is a potential side effect; maintain a healthy diet and exercise routine. Report any fever or pharyngitis to your physician following medication intake.
Uses of Mirglow 7.5mg Tablet
Managing Depressive Disorders
Major Benefits of Mirglow 7.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Mirglow 7.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Mirglow 7.5mg Tablet:
- Sleepiness
- Dryness in mouth
- Increased appetite
- Headache
- Weight gain
How to use Mirglow 7.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 7.5mg Mirglow Tablet whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, however, consistent timing is recommended.
How Mirglow 7.5mg Tablet works:
Lumino 7.5mg tablets alleviate depression by boosting brain levels of serotonin and noradrenaline, neurotransmitters vital for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mirglow 7.5mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Mirglow 7.5mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Mirglow 7.5mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant. Close observation of the infant for developmental issues and growth is recommended.
DrivingUNSAFE
Driving may be affected by Mirglow 7.5mg Tablet side effects, which can reduce concentration and alertness. This medication may impair your ability to drive safely.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Mirglow 7.5mg tablets. Dosage modification of Mirglow 7.5mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Mirglow 7.5mg tablets. Dosage modification for Mirglow 7.5mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Mirglow 7.5mg Tablet :
For Mirglow 7.5mg Tablets, take a missed dose as quickly as you remember. If your next dose is imminent, however, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mirglow 7.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Tetracyclic Piperazinoazepine |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Behavioral Class | Norepinephrine and serotonin-specific antidepressants (NaSSAs) |
3,018 People bought this recently